NHS to trial a pioneering twice-yearly cholesterol injection

The Government has announced an in-principle agreement with Novartis to introduce its investigational drug inclisiran as a preventative add-on treatment to statins for patients who have already been diagnosed with cardiovascular disease.  Recent trials have shown that the twice-yearly cholesterol injection can halve LDL cholesterol in just two weeks. It will be studied in UK patients as part of a large-scale NHS clinical trial expected to start later this year. Health and Social Care Secretary Matt Hancock said: “This partnership is fantastic news and is a huge stride forwards in helping to achieve this. This collaboration has the potential to save 30,000 lives over the next